Medication info
Beacept 5 mg Tablets (Donepezil Hydrochloride Monohydrate)

Beacept 5 mg Tablets (Donepezil Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Donepezil Hydrochloride Hydrate›5.22mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 201602676 · Approved 2016.05.16 · Insurance code 694001110

Summary

Main use
Treatment of symptoms of Alzheimer-type dementia
Who takes it
Adults · Children
Adult dose
○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effect gradually decreases, and no rebound effect occurs following abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.
Child dose
○ Children: There is no experience with use in children.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer-type dementia

  • Symptoms of Alzheimer's dementia
View approved original text

This medication is used to improve symptoms of Alzheimer's dementia. It helps alleviate major issues of this condition such as memory decline and cognitive dysfunction. It also contributes to improving the daily living abilities of dementia patients and aids in overall mental health status improvement. Therefore, it is effectively used in the management of patients with Alzheimer's dementia.

How to take

Adult dose

○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effect gradually decreases, and no rebound effect occurs following abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.

Child dose

○ Children: There is no experience with use in children.

Precautions

This medication uses Donepezil Hydrochloride Monohydrate as its main ingredient to treat symptoms of Alzheimer's dementia. First, this medication should not be used by certain patients. For example, patients who are allergic to this medication or its components, women who are pregnant or may become pregnant, and women who are breastfeeding should not take this medication. Additionally, patients with heart disease, a history of peptic ulcers, asthma or chronic obstructive pulmonary disease, and those with extrapyramidal disorders such as Parkinson's disease should use this medication with caution. This medication can slow heart rate or induce arrhythmias, and could increase stomach acid secretion, potentially worsening symptoms of peptic ulcers. Severe side effects such as fainting, heart problems, gastrointestinal bleeding, liver function abnormalities, seizures, movement disorders, severe muscle issues, shortness of breath, acute pancreatitis, acute renal failure, and sudden death may occur while taking this medication, thus if any of these symptoms appear, immediate consultation with a physician is required. Additionally, various side effects can occur, frequently reported symptoms include nausea, vomiting, diarrhea, dizziness, insomnia, appetite loss, headaches, and fatigue. Furthermore, symptoms such as hallucinations, anxiety, aggressive behavior, irregular heartbeats, skin rashes have also been reported, and any unusual symptoms should be communicated to medical personnel. This medication is not approved for use in other forms of dementia or memory disorders other than Alzheimer's dementia, and treatment should be conducted under the supervision of an experienced physician. The therapeutic effect should be regularly evaluated, and discontinuation should be considered if necessary. Patients with heart disease or electrolyte imbalances may be at risk for arrhythmias while taking this medication and may require electrocardiogram monitoring. Patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs should monitor for gastrointestinal symptoms. This medication may affect driving ability or machine operation, so caution is advised during initial use or upon dosage changes. Moreover, this medication can interact with multiple drugs, so if other medications are being taken, it must be disclosed to a physician or pharmacist. Particular caution is advised when used concurrently with drugs that affect CYP3A4 and CYP2D6 enzymes, drugs that impact cardiac conduction, anticholinergic drugs, cholinergic drugs, etc. Women who are pregnant or breastfeeding should preferably avoid this medication, and if absolutely necessary, consultation with a healthcare professional should be sought before discontinuing breastfeeding. Safety in pediatric patients has not been established, and this medication should not be used in children. This medication may affect muscle enzyme and liver function test results, necessitating regular testing. In cases of overdose, severe vomiting, bradycardia, hypotension, respiratory depression, and convulsions may occur, requiring immediate medical treatment. Atropine may be used as an antidote. Lastly, this medication should be kept out of reach of children and transferring it to another container can lead to quality degradation or accidents.

Side effects

Syncope, bradycardia, heart block, QT interval prolongation, myocardial infarction, heart failure, peptic ulcer, perforated duodenal ulcer, gastrointestinal bleeding, hepatitis, liver dysfunction, jaundice, cerebral seizure, cerebral hemorrhage, cerebrovascular disorder, motor dysfunction, ataxia, movement disorder, dystonia, tremor, involuntary movement, gait disturbance, abnormal posture, speech disorder, akinetic mutism, severe muscle rigidity, dysphagia, tachycardia, blood pressure fluctuations, sweating, myalgia, malaise, dyspnea, acute pancreatitis, acute kidney failure, sudden death of unknown cause, cold, decreased appetite, hallucination, agitation, aggressive behavior, anxiety disorder, insomnia, drowsiness, increased libido, talkativeness, manic episode, nightmares, irritability, nonsensical talk, delusion, depression, confusion, apathy, hyperactivity, increased sexual desire, hypersexuality, dizziness, tremor, seizure, stupor, chest rigidity, palpitations, sinoatrial block, atrioventricular block, hypertension, hypotension, atrial fibrillation, torsades de pointes ventricular tachycardia, ECG QT interval prolongation, diarrhea, nausea, vomiting, abdominal disorder, gastric and duodenal ulcer, constipation, salivation, fecal incontinence, liver impairment, rash, itching, muscle cramp, urinary incontinence, frequency, urinary retention, headache, fatigue, pain, dental pain, facial flushing, lethargy, weakness, edema, fever, decreased body temperature, decreased hematocrit, leukopenia, anemia, thrombocytopenia, falls, cardiac arrest, urinary tract infection, decreased appetite, dehydration, hyperlipidemia, hostility, irritability, confusion, emotional instability, personality disorder, eczema, cystitis, hematuria, diabetes, vaginitis, urination disorder, proteinuria, petechiae, abnormal dreams, abdominal pain, anxiety, cholecystitis, hemolytic anemia, hyponatremia, pancreatitis, skin rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, ideally at room temperature between 1 degree and 30 degrees Celsius. This storage method will help maintain the efficacy of the drug and prevent deterioration.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.